Zofenopril Calcium, an
angiotensin-converting enzyme (ACE) inhibitor, is widely utilized in the clinical management of
hypertension and
heart failure. Commercially available under various trade names such as Zofecor, it is a drug that targets the renin-angiotensin-aldosterone system (RAAS). Developed and researched by numerous pharmaceutical institutions, Zofenopril Calcium has shown considerable promise due to its prolonged effect and favorable side effect profile compared to other ACE inhibitors. Several clinical trials have established its efficacy in lowering blood pressure and protecting cardiac function, making it a cornerstone in cardiovascular therapy.
Zofenopril Calcium Mechanism of Action
The mechanism of action of Zofenopril Calcium revolves around its inhibition of the angiotensin-converting enzyme, which is a critical component of the RAAS. By inhibiting this enzyme, Zofenopril Calcium effectively blocks the conversion of angiotensin I to
angiotensin II, a potent vasoconstrictor. Angiotensin II also stimulates the release of aldosterone, leading to sodium and water retention. By reducing the levels of angiotensin II and
aldosterone, Zofenopril Calcium promotes vasodilation, reduces blood volume, and ultimately decreases blood pressure. Additionally, the reduction in angiotensin II levels results in less strain on the heart, making it easier for the heart to pump blood, which is particularly beneficial in heart failure patients.
How to Use Zofenopril Calcium
Zofenopril Calcium is typically administered orally in the form of tablets. The dosage varies based on the condition being treated and the patient's response to the medication. For hypertension, the initial dose is often 15 mg once daily, which may be adjusted according to the patient's blood pressure response. For heart failure, the starting dose is usually lower, around 7.5 mg, with gradual titration to minimize the risk of adverse effects.
The onset of action for blood pressure reduction generally occurs within 1 hour of oral administration, with the peak effect seen between 3 to 7 hours. For heart failure, the therapeutic effects may take longer to become evident, often requiring several weeks of continuous treatment. It is essential for patients to adhere to their prescribed regimen and to consult their healthcare provider regularly to monitor the drug's effectiveness and make any necessary dosage adjustments.
What is Zofenopril Calcium Side Effects
Like all medications, Zofenopril Calcium can cause side effects, although not everyone experiences them. Common side effects include
cough,
dizziness,
headache, and
fatigue. These symptoms are generally mild and often diminish as the body adjusts to the medication. However, some side effects can be more serious and require immediate medical attention. These include
swelling of the face, lips, or throat (
angioedema), severe
abdominal pain,
jaundice (a sign of liver dysfunction), and significant drops in blood pressure (
hypotension).
Contraindications for Zofenopril Calcium include a history of angioedema related to previous ACE inhibitor therapy,
hereditary or idiopathic angioedema, and pregnancy due to the risk of fetal harm. Patients with
renal impairment or a history of severe
hypersensitivity reactions should use this medication with caution. It is also advised to avoid Zofenopril Calcium in patients with
bilateral renal artery stenosis or in those who are concurrently taking
aliskiren, especially in patients with
diabetes or renal impairment.
What Other Drugs Will Affect Zofenopril Calcium
Zofenopril Calcium can interact with several other medications, potentially altering its efficacy or increasing the risk of adverse effects. Concomitant use with diuretics, particularly potassium-sparing diuretics such as
spironolactone and
eplerenone, can increase the risk of
hyperkalemia, a condition characterized by elevated potassium levels in the blood. Nonsteroidal anti-inflammatory drugs (NSAIDs) like
ibuprofen and
naproxen may reduce the antihypertensive effects of Zofenopril Calcium and increase the risk of renal impairment.
Other ACE inhibitors or
angiotensin II receptor blockers (ARBs) should generally be avoided, as combining these agents can lead to excessive blood pressure reduction and an increased risk of kidney problems.
Lithium, when taken with Zofenopril Calcium, can result in increased serum lithium levels, raising the risk of lithium toxicity. Additionally, drugs that can increase potassium levels, such as potassium supplements or salt substitutes containing potassium, should be used cautiously to avoid hyperkalemia.
Patients should inform their healthcare provider of all medications they are currently taking, including over-the-counter drugs, supplements, and herbal products, to ensure there are no harmful interactions. Regular monitoring and periodic blood tests are crucial for patients on Zofenopril Calcium to manage potential drug interactions and side effects effectively.
In summary, Zofenopril Calcium is a potent ACE inhibitor with significant benefits in treating hypertension and heart failure. Its mechanism of action involves the inhibition of the renin-angiotensin-aldosterone system, leading to vasodilation and reduced blood volume. While generally well-tolerated, it can cause side effects, some of which may be severe. Understanding its interactions with other drugs is essential for optimizing treatment outcomes and minimizing risks. As always, patients should closely follow their healthcare provider’s guidance and report any unusual symptoms or concerns promptly.
How to obtain the latest development progress of all drugs?
In the Synapse database, you can stay updated on the latest research and development advances of all drugs. This service is accessible anytime and anywhere, with updates available daily or weekly. Use the "Set Alert" function to stay informed. Click on the image below to embark on a brand new journey of drug discovery!


